References

Abedin M, Tintut Y, Demer LL. Mesenchymal stem cells and the artery wall. Circ Res.95:671-6. 2004.

 

Artman GM. And Chen S., 2008, Bioengineering in Cell and Tissue Research, Springer publishing, page 198.

 

Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol.36:568-84. 2004.

 

Barry F, Boynton RE, Liu B, Murphy JM. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res.268:189-200. 2001.

 

Barry FP, Murphy JM, English K, Mahon BP. Immunogenicity of adult mesenchymal stem cells: lessons from the fetal allograft. Stem Cells Dev.14:252-65. 2005.

 

Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol.30:42-8. 2002.

 

Bruder SP, Jaiswal N and Haynesworth SE. 1997. Growth kinetics, self-renewal and the osteogenic potential of purified human mesenchymal stem cells during extensive sub cultivation and following cryopreservation. J. Cell. Biochem. 64: 278-294.

 

Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C. Adipose-derived stem cells: isolation, expansion and differentiation. Methods.45:115-20. 2008.

 

Caplan A. I. and Bruder S. P. 2001. Mesenchymal Stem Cells; building blocks for molecular medicine in the 21st century. Trends in Molecular Medicine, Volume 7; pp. 259-264.

 

Caplan A. I., 2007, Adult Mesenchymal Stem Cells for Tissue Engineering Versus Regenerative Medicine. Journal of Cell Physiology, Volume 213; pp. 341-347.

 

Caplan AI. Mesenchymal stem cells. J Orthop Res.9:641-50. 1991.

 

Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell.3:301-13. 2008.

 

Caplan AI. All MSCs are pericytes? Cell Stem Cell.3:229-30. 2008.

 

Carrancio S., a, c, d, *López-Holgado N.a, c, d, *, Sánchez-Guijo F. M.a, c, d, Villarón E.a, c, d, Barbado V.a, c, d, Tabera S.a, c, d, Díez-Campelo M.a, c, d, Blanco J.b, d, San Miguel J. F.a, c, d and Consuelo del Cañizo M. 2008. Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol., May 9.

 

da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci.119:2204-13. 2006.

 

Deng W, Han Q, Liao L, Li C, Ge W, Zhao Z, et al. Allogeneic bone marrow-derived flk-1+Sca-1- mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance. Exp Hematol.32:861-7. 2004.

 

Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol.107:275-81. 1999.

 

Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, FC., Krause, D.S., Deans, R.J., Keating, A., Prockop D.J. and Horwitz, E.M. (2006). Position Paper: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) Vol. 8, No. 4, pp315 - 317.

 

English K, Barry FP, Mahon BP. Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol Lett.115:50-8. 2008.

 

English K, Ryan JM, Tobin L, Murphy MJ, Barry FP, Mahon BP. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin Exp Immunol.156:149-60. 2009.

 

English K, Barry FP, Field-Corbett CP, Mahon BP. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol Lett.110:91-100. 2007.

 

Friedenstein AJ, Piatetzky S, II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol.16:381-90. 1966.

 

Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation.17:331-40. 1974.

 

Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet.3:393-403. 1970.

 

Friedenstein AJ. Marrow stromal fibroblasts. Calcif Tissue Int.56 Suppl 1:S17. 1995.

 

Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res.100:1249-60. 2007.

 

Giordano A., Galderisi U., Marino I., 2007, From the laboratory bench to the patient's bedside; An update on clinical trials with mesenchymal stem cells, J. Cell Physiol., 211; 27-35.

 

Goshima J. Goldberg VM, Caplan AI 1991. The osteogenic potential of culture-expaneded rat marrow stromal cells assayed in vivo in calcium phosphate ceramic blocks. Clin Orthop Relat Res 262:228-311.

 

Guo K.T., Schafer R., Paul A., Gerber A., Ziemer G., Wendel H. P., 2006. A New Technique for the Isolation and Surface Immobilization of Mesenchymal Stem Cells from Whole Bone Marrow Using High-Specific DNA Aptamers. Stem Cells, 24; pp. 2220 - 2231.

 

Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. 1992. Characterization of cells with osteogenic potential from human bone marrow. Bone 13: 81-88

 

Hoffmann A, Pelled G, Turgeman G, Eberle P, Zilberman Y, Shinar H, Keinan-Adamsky K, Winkel A, Shahab S, Navon G., 2006, Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells, J. Clin. Invest., 116: 940-952.

 

Jiang Y, Vaessen B, Lenvik t, Blackstad M, Reyes M, Verfaillie CM., 2002. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle and brain. Exp Hematol 30; pp896-904.

 

Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood.105:4120-6. 2005.

 

Kassis I., Zangi L., Rivkin R., Levdansky L., Samuel S., Marx G., Gorodetsky R., 2006, Isolation of mesenchymal stem cells from GCSF-mobilized human peripheral blood using fibrin microbeads, Bone Marrow Transplant., 37: 967-976.

 

Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther.9:204. 2007.

 

Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood.101:3722-9. 2003.

 

Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol.31:890-6. 2003.

 

Lodie TA, Blickarz CE, Devarakonda TJ, He C, Dash AB, Clarke J, et al. Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction. Tissue Eng.8:739-51. 2002.

 

Logeart-Avramoglou D., Anagnostou F., Bizios R. 2005. Engineering bone; Challenges and Obstacles. J. Cell Mol. Med., 9; pp. 72 - 84.

 

Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology.138:4456-62. 1997.

 

Mansilla E., Marin GH., Drago H., Sturla F., Salas E., Gardiner C., Bossi S., Lamonega R., Guzman A., Nunez A., Gil MA., Piccinelli G., Ibar R., Soratti C., 2006, Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: New evidence for their use in regenerative medicine, Transplant Proc., 38: 967-969.

 

Mastrogiacomo M, Corsi A, Francioso E, Di Comite M, Monetti F, Scaglione S, Favia A, Crovace A, Bianco P, Cancedda R. 2006. Reconstruction of extensive long bone defects in sheep using resorbable bioceramics based on silicon stabilized tricalcium phosphate. Tissue Eng. 12: 1261-1273.

 

McBride C, Gaupp D, Phinney DG. Quantifying levels of transplanted murine and human mesenchymal stem cells in vivo by real-time PCR. Cytotherapy.5:7-18. 2003.

 

Meliga E, Strem BM, Duckers HJ, Serruys PW. Adipose-derived cells. Cell Transplant.16:963-70. 2007.

 

Mody N, Tintut Y, Radcliff K, Demer LL. Vascular calcification and its relation to bone calcification: possible underlying mechanisms. J Nucl Cardiol.10:177-83. 2003.

 

Murphy JM, Dixon K, Beck S, Fabian D, Feldman A, Barry F. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum.46:704-13. 2002.

 

Owen M, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp.136:42-60. 1988.

 

Phinney DG, Kopen G, Isaacson RL, Prockop DJ. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem.72:570-85. 1999.

 

Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science.284:143-7. 1999.

 

Polchert D, Sobinsky J, Douglas G, Kidd M, Moadsiri A, Reina E, et al. IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol.38:1745-55. 2008.

 

Potian JA, Aviv H, Ponzio NM, Harrison JS, Rameshwar P. Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol.171:3426-34. 2003.

 

Pytlik R, Stehlik D, Soukup T, Kalbacova M, Rypacek F, Trc T, Mulinkova k, Michnova P, Kideryova L, Zivny J, Klener P, Vesela R, Trneny M, Klener P. 2009. The Cultivation of Human Multipotent Mesenchymal Stem Cells in Clinical Grade Medium for Bone Tissue Engineering. Biomaterials, 2009; 30 pp 3415-3427.

 

Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E, Marcacci M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med. 2001 Feb 1;344(5):385-6

 

Reid JW, Pietak A, Sayer M, Dunfield D, Smith TJ. Phase formation and evolution in the silicon substituted tricalcium phosphate/apatite system. Biomatrerials 26 2887, 2005.

 

Ryan JM, Barry FP, Murphy JM, Mahon BP. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond).2:8. 2005.

 

Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell.131:324-36. 2007.

 

Shahdadfar A., Fronsdal K., Haug T., Reinholt F. P. and Brinchmann J. E.. In Vitro Expansion of Human Mesenchymal Stem Cells: Choice of Serum Is a Determinant of Cell Proliferation, Differentiation, Gene Expression, and Transcriptome Stability. Stem Cells, 2005; 23 pp. 1357-1366.

 

Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res.18:696-704. 2003.

 

Sorrentino A., Ferracin M., Castelli G., Biffoni M., Tomaselli G., Baiocchi M., Fatica A., Negrini M., Peschle C., Valtieri M. 2008. Isolation and characterization of CD126(+) multipotent mesenchymal stromal cells. Exp. Hematol., May 24

 

Sotiropoulou, P.A., Perez, S.A., Salagianni, M., Baxevanis, C.N., Papamichail, M. (2006). Characterization of the Optimal Culture Conditions for Clinical Scale Production of Human Mesenchymal Stem Cells. Stem Cells 2006;24:462-471

 

Tavian M, Zheng B, Oberlin E, Crisan M, Sun B, Huard J, et al. The vascular wall as a source of stem cells. Ann N Y Acad Sci.1044:41-50. 2005.

 

Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Bostrom K, et al. Multilineage potential of cells from the artery wall. Circulation.108:2505-10. 2003.

 

Troyer DL, Weiss ML. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells.26:591-9. 2008.

 

Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation.75:389-97. 2003.

 

Valtieri M. And Sorrentino A., 2008, The Mesenchymal Stromal Cell Contribution to Homeostasis, Journal of Cell. Physiol., 217; 296-300.

 

Wagner W., Wein F., Seckinger A., 2005, Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood, Exp Hematol., 33: 1402-1416.

 

Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells.24:781-92. 2006.

 

Weiss ML, Troyer DL. Stem cells in the umbilical cord. Stem Cell Rev.2:155-62. 2006.

 

Flynn A, Barry F, O'Brien T. UC blood-derived mesenchymal stromal cells: an overview. Cytotherapy.9:717-26. 2007.

 

Zannettino AC, Paton S, Arthur A, Khor F, Itescu S, Gimble JM, et al. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol.214:413-21. 2008.

 

Zhang W, Ge W, Li C, You S, Liao L, Han Q, et al. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev.13:263-71. 2004.